A recent publication in British Medical Journal titled “Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis”, conclu[...]
On October 19th, 2010 the FDA approved the drug Pradaxa (dabigatran) for prevention of stroke and blood clots in people with abnormal heart rhythm (atrial fibrillation). As compare[...]
The FDA just released last week another warning about the relationship between the use of bisphosphonates (Fosamax (alendronate), Actonel (risedronate), Bonvia (ibandronate)), and [...]